5Mar2019The Biotech Industry Can Help Address the Opioid Crisis. But We Aren’t Doing Enough/Alex Harding/0/All, Drugs05 Mar 2019Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.